×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IRMD – iradimed corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IRMD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/27
09:12 am
irmd
Redditors Say IRadimed (IRMD) is Among The Best Small-Cap Stocks to Buy – Here's Why [Yahoo! Finance]
Low
Report
Redditors Say IRadimed (IRMD) is Among The Best Small-Cap Stocks to Buy – Here's Why [Yahoo! Finance]
11/10
10:01 am
irmd
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026 [Yahoo! Finance]
Low
Report
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026 [Yahoo! Finance]
11/10
09:00 am
irmd
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
Low
Report
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
11/9
07:03 pm
irmd
Read This Before Considering IRADIMED CORPORATION (NASDAQ:IRMD) For Its Upcoming US$0.17 Dividend [Yahoo! Finance]
Low
Report
Read This Before Considering IRADIMED CORPORATION (NASDAQ:IRMD) For Its Upcoming US$0.17 Dividend [Yahoo! Finance]
11/6
06:56 am
irmd
iRadimed (NASDAQ:IRMD) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
iRadimed (NASDAQ:IRMD) was upgraded by analysts at Zacks Research to a "hold" rating.
11/3
05:03 pm
irmd
iRadimed (NASDAQ:IRMD) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
Medium
Report
iRadimed (NASDAQ:IRMD) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
11/3
08:30 am
irmd
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results
Medium
Report
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results
11/1
06:55 am
irmd
iRadimed (NASDAQ:IRMD) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Medium
Report
iRadimed (NASDAQ:IRMD) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/2
04:05 pm
irmd
Form 4 IRADIMED CORP For: Dec 01 Filed by: Susi Roger E.
Low
Report
Form 4 IRADIMED CORP For: Dec 01 Filed by: Susi Roger E.
11/24
05:00 pm
irmd
Form 4 IRADIMED CORP For: Nov 24 Filed by: Susi Roger E.
Low
Report
Form 4 IRADIMED CORP For: Nov 24 Filed by: Susi Roger E.
11/21
04:05 pm
irmd
Form 4 IRADIMED CORP For: Nov 20 Filed by: HAWKINS JAMES B
Low
Report
Form 4 IRADIMED CORP For: Nov 20 Filed by: HAWKINS JAMES B
11/20
06:42 pm
irmd
Form 144 IRADIMED CORP Filed by: HAWKINS JAMES B
Low
Report
Form 144 IRADIMED CORP Filed by: HAWKINS JAMES B
11/19
12:05 pm
irmd
Form 4 IRADIMED CORP For: Nov 18 Filed by: Susi Roger E.
Low
Report
Form 4 IRADIMED CORP For: Nov 18 Filed by: Susi Roger E.
11/12
04:00 pm
irmd
Form 4 IRADIMED CORP For: Nov 10 Filed by: GLENN JOHN
Low
Report
Form 4 IRADIMED CORP For: Nov 10 Filed by: GLENN JOHN
11/12
04:00 pm
irmd
Form 4 IRADIMED CORP For: Nov 10 Filed by: Susi Roger E.
Low
Report
Form 4 IRADIMED CORP For: Nov 10 Filed by: Susi Roger E.
11/10
06:55 pm
irmd
Form 144 IRADIMED CORP Filed by: GLENN JOHN
Low
Report
Form 144 IRADIMED CORP Filed by: GLENN JOHN
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
7/29
Form 8-K IRADIMED CORP For: Jul 29
33.3%
9/12 Form 4 IRADIMED CORP For: Sep 10 Filed by: JOHNSON BRENT 13.4%
3/24 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock. 12.5%
3/31 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock. 9.7%
12/11 Form 4 IRADIMED CORP For: Dec 09 Filed by: JOHNSON BRENT 7.7%
2/6 IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results 7.1%
4/3 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.9%
10/30 Q3/2019 9/30/2019 EPS 0.230 ZacksConsensus 0.130 ActVsEst 0.100 - Beat 5.7%
4/14 Iradimed Corp (NASDAQ: IRMD) had its price target lowered by analysts at Roth Capital from $32.00 to $30.00. 5.0%
8/7 Form 4 IRADIMED CORP For: Aug 05 Filed by: JOHNSON BRENT 4.9%
9/12 Form 4 IRADIMED CORP For: Sep 10 Filed by: JOHNSON BRENT 13.4%
3/24 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock. 12.5%
3/31 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock. 9.7%
12/11 Form 4 IRADIMED CORP For: Dec 09 Filed by: JOHNSON BRENT 7.7%
2/6 IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results 7.1%
4/3 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.9%
10/30 Q3/2019 9/30/2019 EPS 0.230 ZacksConsensus 0.130 ActVsEst 0.100 - Beat 5.7%
4/14 Iradimed Corp (NASDAQ: IRMD) had its price target lowered by analysts at Roth Capital from $32.00 to $30.00. 5.0%
8/7 Form 4 IRADIMED CORP For: Aug 05 Filed by: JOHNSON BRENT 4.9%
TOP News Decliners
4/30
Form 8-K IRADIMED CORP For: Apr 30
-9.0%
3/12 IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development -7.8%
5/7 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -6.1%
11/1 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
2/25 Form 4 IRADIMED CORP For: Feb 24 Filed by: JOHNSON BRENT -5.6%
2/28 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -5.1%
8/5 Form 4 IRADIMED CORP For: Aug 01 Filed by: Waldman Louis S. -5.1%
11/5 Form 4 IRADIMED CORP For: Nov 04 Filed by: Nardi Steven M. -4.9%
3/26 Form 4 IRADIMED CORP For: Mar 24 Filed by: JOHNSON BRENT -4.5%
3/4 Form 4 IRADIMED CORP For: Mar 02 Filed by: JOHNSON BRENT -3.9%
3/12 IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development -7.8%
5/7 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -6.1%
11/1 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
2/25 Form 4 IRADIMED CORP For: Feb 24 Filed by: JOHNSON BRENT -5.6%
2/28 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -5.1%
8/5 Form 4 IRADIMED CORP For: Aug 01 Filed by: Waldman Louis S. -5.1%
11/5 Form 4 IRADIMED CORP For: Nov 04 Filed by: Nardi Steven M. -4.9%
3/26 Form 4 IRADIMED CORP For: Mar 24 Filed by: JOHNSON BRENT -4.5%
3/4 Form 4 IRADIMED CORP For: Mar 02 Filed by: JOHNSON BRENT -3.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: